Zema Global, a leading provider of data management and analytics solutions for companies engaged in the energy, commodities and financial sectors, today announced the acquisition of cQuant.io, an industry leader in analytic solutions for energy and commodity companies. The acquisition, supported by Zema Global’s existing investor FTV Capital, marks a significant step in the company’s mission to deliver real-time, enterprise-grade insights that transform how energy and commodity firms operate. ...
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that the Mobile Learning Unit (MLU) at the University of Melbourne has selected Rimini Manage™ and Rimini Consult™ for Salesforce as its strategy to bring stability and enhancement to its eLearning platform. This press release features multimedia. View the full release here: htt...
Seoul Semiconductor Co., Ltd. (KOSDAQ: 046890), a leading global innovator of LED products and technology, announced that the Local Division Paris of the Unified Patent Court (UPC), which has jurisdiction across 18 European countries, has issued a judgment that Laser Components SAS infringed Seoul Semiconductor affiliate’s core optical semiconductor patent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428172182/en/Comparison of ...
Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces the launch of Generix Resource Management Systems (RMS), a new AI-powered application that optimizes all warehouse resources through intelligent forecasting, planning, and analytics – all in a single environment. As many warehouse management teams struggle to keep pace with supply chain disruptions with error-prone, disparate ma...
Takeda (TSE: 4502/NYSE:TAK) today announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes NT1. Results demonstrated significant improvement in objective and subjective measures of excessive daytime sleepiness (EDS), reduction...
VeriSilicon (688521.SH) today unveiled its ISP9000 series Image Signal Processing (ISP) IP, a next-generation AI-embedded ISP solution designed to address the evolving demands of intelligent vision applications. Built on a flexible AI-optimized architecture, ISP9000 delivers exceptional image quality, low-latency multi-sensor management, and seamless AI integration, making it ideal for advanced use cases, such as intelligent machines, surveillance cameras, and AI PCs. With its AI-powered ISP c...
Global IT firm FPT and GE HealthCare announced a Strategic Cooperation Agreement, expanding their commercial alliance to advance product strategy and development, and establish an FPT Competency Center in Vietnam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401306987/en/ This deepening collaboration reflects a strategic shift from project-based engagement to a long-term alliance aimed at accelerating the adoption of AI-driven s...
Desentum Oy, a clinical-stage biopharmaceutical company developing novel immunotherapies for treating allergies, announces positive clinical data with birch pollen allergy vaccine DM-101PX. The short-course treatment was found to be safe and well tolerated in birch pollen allergic patients and to induce a very strong and sustained allergen-specific IgG4 response. DM-101PX-induced immunoglobulins were found to efficiently block IgE-mediated basophil activation endorsing the product’s potential t...